
According to Benzinga Pro, during Q1, Surface Oncology (NASDAQ:SURF) earned $6.20 million, a 125.78% increase from the preceding quarter. Surface Oncology also posted a total of $30.00 million in sales, a 19380.52% increase since Q4. Surface Oncology collected $154.00 thousand in revenue during Q4, but reported earnings showed a $24.05 million loss.